HomeBIAF • NASDAQ
add
bioAffinity Technologies Inc
Previous close
$0.28
Day range
$0.27 - $0.28
Year range
$0.16 - $2.99
Market cap
7.80M USD
Avg Volume
6.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 1.85M | -22.97% |
Operating expense | 3.11M | 12.05% |
Net income | -2.66M | -35.61% |
Net profit margin | -143.53 | -76.05% |
Earnings per share | -0.16 | — |
EBITDA | -2.57M | -35.78% |
Effective tax rate | -0.33% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 444.71K | -81.87% |
Total assets | 5.55M | -31.08% |
Total liabilities | 4.11M | 47.12% |
Total equity | 1.44M | — |
Shares outstanding | 26.82M | — |
Price to book | 3.52 | — |
Return on assets | -108.91% | — |
Return on capital | -191.10% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -2.66M | -35.61% |
Cash from operations | -1.64M | 30.02% |
Cash from investing | -50.79K | -22.71% |
Cash from financing | 1.03M | -48.89% |
Net change in cash | -660.58K | -79.31% |
Free cash flow | -684.21K | 58.70% |
About
Founded
2014
Headquarters
Website
Employees
57